LETTER
One-Pot Synthesis of 7-Trifluoromethyl-Substituted Imidazo[4,5-b]pyridines
1461
Table 2 Variation of Scaffold Substitution Pattern Depending on Initial 1,3-Biselectrophile
O
O
RF
N
R
RF
PMB amine
N
N
N
N
CN
2b
4a–e
NH2
O
1
R
PMB
3
PMB
5
Compound
R
RF
Yield (%)a
5k
5l
Me
Ph
CF3
CF3
55
60
23
48
25
5m
5n
5o
Me
Me
CF3
C2F5
CHF2
CF3
a Yields refer to isolated products.
Westerhout, J.; Spangenberg, T.; Brussee, J.; Ijzerman, A. P.
J. Med. Chem. 2007, 50, 828. (d) Mladenova, G.; Lee-Ruff,
E. Tetrahedron Lett. 2007, 48, 2787.
lower than the LUMO energy level of the nonfluorinated
analogues. These properties and our experimental results
in mind we suppose, that the regiochemistry could be ex-
plained by the hard–soft acid–base (HSAB) principle.22
We could not yet observe other effects which control the
regioselectivity.
(6) (a) Lawhorn, B. G.; Mehl, R. A.; Begley, T. P. Org. Biomol.
Chem. 2004, 2, 2538. (b) Clayton, R.; Davis, M. L.; Fraser,
W.; Li, W.; Ramsden, C. A. Synlett 2002, 1483.
(c) Humphries, M. J.; Ramsden, C. A. Synthesis 1999, 985.
(7) Bhat, B.; Groziak, M. P.; Leonard, N. J. J. Am. Chem. Soc.
1990, 112, 4891.
(8) (a) Bégué, J.-P.; Bonnet-Delpon, D. In Chimie Bioorganique
et Médicinale du Fluor; CNRS Édition: Paris, 2005.
(b) Hiyama, T. In Organofluorine Compounds, Chemistry
and Applications; Springer: Berlin, Heidelberg, 2000.
(9) (a) McClinton, M. A.; McClinton, D. A. Tetrahedron 1992,
48, 6555. (b) Nowak, I.; Robins, M. J. J. Org. Chem. 2007,
72, 2678.
In summary, we have developed a useful tool to synthe-
size 5,7-disubstituted imidazo[4,5-b]pyridines in a one-
pot reaction. With this approach it was possible to intro-
duce a CF3 group selectively in para position to the pyri-
dine nitrogen.
Acknowledgment
(10) Ohkura, H.; Berbarasov, D. O.; Soloshonok, V. A.
Tetrahedron Lett. 2003, 44, 2417.
V. I. thanks the DAAD, Euler program, for a fellowship and the
partnership program between the University of Konstanz and the
NTSU Kiew for having the opportunity to perform his doctoral stu-
dies in Konstanz. We are grateful to the Bayer AG, the Merck
KGaA and the Wacker AG for generous gifts of reagents.
(11) (a) Zanatta, N.; Amaral, S. S.; Esteves-Souza, A.;
Echevarria, A.; Brondani, P. B.; Flores, D. C.; Bonacorso, H.
G.; Flores, A. F. C.; Martins, M. A. P. Synthesis 2006, 2305.
(b) Marins, M. A. P.; Pereira, C. M. P.; Zimmermann, N. E.
K.; Cunico, W.; Moura, S.; Beck, P.; Zanatta, N.; Bonacorso,
H. G. J. Fluorine Chem. 2003, 123, 261; and references cited
therein. (c) Narsaiah, B.; Sivaprasad, A.; Venkataratnam, R.
V. J. Fluorine Chem. 1994, 66, 47. (d)Schlosser, M.;Volle,
J.-N.; Leroux, F.; Schenk, K. Eur. J. Org. Chem. 2002,
2913. (e) Druzhinin, S. D.; Balenkova, E. S.; Nenajdenko,
V. G. Tetrahedron 2007, 63, 7753.
(12) (a) Krasovsky, A. L.; Hartulyari, A. S.; Nenajdenko, V. G.;
Balenkova, E. S. Synthesis 2002, 133. (b) Krasovsky, A. L.;
Moiseev, A. M.; Nenajdenko, V. G.; Balenkova, E. S.
Synthesis 2002, 901.
(13) (a) Tamura, K.; Mizukami, H.; Maeda, K.; Watanabe, H.;
Uneyama, K. J. Org. Chem. 1993, 58, 32. (b) Uneyama, K.
J. Fluorine Chem. 1999, 97, 11.
References and Notes
(1) (a) Temple, C.; Rose, J. D.; Comber, R. N.; Rener, G. A.
J. Med. Chem. 1987, 30, 1746. (b) Cristalli, G.; Vittori, S.;
Eleuteri, A.; Grifantini, M.; Volpini, R.; Lupidi, G.;
Capolongo, L.; Pesenti, E. J. Med. Chem. 1991, 34, 2226.
(2) (a) Cristalli, G.; Vittori, S.; Eleuteri, A.; Volpini, R.;
Camaioni, E.; Lupidi, G.; Mohmoud, N.; Belvilaqua, F.;
Palu, G. J. Med. Chem. 1995, 38, 4019. (b) Cundy, D. J.;
Holan, G.; Otaegui, M.; Simpson, G. W. Bioorg. Med.
Chem. Lett. 1997, 7, 669.
(3) Temple, C. J. Med. Chem. 1990, 33, 656.
(4) Bukoski, L.; Janowiec, M. Pharmazie 1989, 44, 267.
(5) (a) Mantlo, N. B.; Chakravarty, P. K.; Ondeyka, D. L.; Siegl,
P. K. S.; Chang, R. S.; Lotti, V. J.; Faust, K. A.; Chen, T.-B.;
Schorn, T. W.; Sweet, C. S.; Emmert, S. E.; Patchett, A. A.;
Greenlee, W. J. J. Med. Chem. 1991, 34, 2922.
(14) Gaudry, R. Org. Synth. 1955, 3, 436.
(15) Menge, G. A. J. Am. Chem. Soc. 1934, 56, 2197.
(16) Hosmane, R. S.; Brunett, F. N.; Albert, M. S. J. Org. Chem.
1984, 49, 1212.
(b) Bavetsias, V.; Sun, C.; Bouloc, N.; Reynisson, J.;
Workman, P.; Linardopoulos, S.; McDonald, E. Bioorg.
Med. Chem. Lett. 2007, 17, 6567. (c) Chang, L. C. W.; von
Frijtag Drabbe Künzel, J. K.; Mulder-Krieger, T.;
(17) General Procedure
A solution of amine 2a–i (5 mmol) in dried CH2Cl2 (2,5 mL)
was heated until reflux. After a period of 15 min ethyl N-
(cyanomethyl)formimidate 1 (5 mmol, 560 mg) was added
under N2 counterflow. The mixture was allowed to stir
Synlett 2008, No. 10, 1459–1462 © Thieme Stuttgart · New York